Treating Indolent Lymphoma: Common and Rare Types

This activity is intended for hematologist/oncologists, oncology nurses, and other healthcare professionals involved in the care of patients with lymphoma

After completing this CE activity, the participant should be better able to:

• Identify indolent lymphoma subtypes and explain the importance of an accurate diagnosis
• Explain new and emerging treatments for follicular lymphoma, marginal zone, and Waldenstrom’s macroglobulinemia (WM)
• Identify the interprofessional healthcare team’s role in managing a patient with a chronic blood cancer 
• Describe common treatment side effects and patient management 
• Review patient education and support resources